Literature DB >> 2783876

Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein.

K Brixen1, H K Nielsen, E F Eriksen, P Charles, L Mosekilde.   

Abstract

Serum levels of total alkaline phosphatase activity (S-T-AP), wheat germ lectin-precipitated alkaline phosphatase activity (S-L-AP), and bone Gla-protein immunoreactivity (S-BGP) were measured in 26 patients (23 females and 3 males) aged 35-73 years (mean 59 years) with primary hyperparathyroidism (n = 7), hyperthyroidism (n = 9), and hypothyroidism (n = 10) in whom the bone mineralization rate (m) was determined by 47Ca-kinetics (continuously expanding calcium pool model). A weak positive correlation (r = 0.42, P less than 0.05) was found between S-T-AP and m, which in the range from 0-18 mmol Ca/day could be estimated with a standard error of 4.6 mmol/day. A closer correlation (r = 0.65, P less than 0.001) was found between S-L-AP and m which was estimated with an error of 3.9 mmol Ca/day. The AP activity in the supernatant showed no significant correlation to m (r = 0.11, P greater than 0.50). The highest correlation coefficient (r = 0.81, P less than 0.001) was found between S-BGP and m which could be predicted with an error of 3.4 mmol Ca/day. S-BGP showed a closer correlation to S-L-AP (r = 0.71, P less than 0.001) than to S-T-AP (r = 0.58, P less than 0.01). We concluded that S-L-AP predicts bone mineralization at organ level better than S-T-AP in selected metabolic bone disorders and that the supernatant activity shows no relation to bone turnover.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783876     DOI: 10.1007/BF02556467

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  31 in total

1.  CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.

Authors:  L KLEIN; F W LAFFERTY; O H PEARSON; P H CURTISS
Journal:  Metabolism       Date:  1964-03       Impact factor: 8.694

2.  [Catalytic concentration, multiple forms, and lectin affinity of microsomal enzymes from human tissues: lectins as reagents, II (author's transl)].

Authors:  K Lorentz
Journal:  J Clin Chem Clin Biochem       Date:  1981-12

3.  Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma.

Authors:  S B Rosalki; A Y Foo
Journal:  Clin Chem       Date:  1984-07       Impact factor: 8.327

4.  Quantitative method for determining serum alkaline phosphatase isoenzyme activity I. Guanidine hydrochloride: new reagent for selectively inhibiting major serum isoenzymes of alkaline phosphatase.

Authors:  M D Shephard; M J Peake
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

5.  An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.

Authors:  R J Walton; C J Preston; R G Russell; J A Kanis
Journal:  Clin Chim Acta       Date:  1975-09-01       Impact factor: 3.786

6.  Calcium metabolism evaluated by 47Ca kinetics: estimation of dermal calcium loss.

Authors:  P Charles; F T Jensen; L Mosekilde; H H Hansen
Journal:  Clin Sci (Lond)       Date:  1983-10       Impact factor: 6.124

7.  Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.

Authors:  C M Gundberg; D E Cole; J B Lian; T M Reade; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

8.  Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.

Authors:  S E Papapoulos; M Frolich; A H Mudde; H I Harinck; H vd Berg; O L Bijvoet
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

9.  Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility.

Authors:  W Behr; J Barnert
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

10.  Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.

Authors:  L Mosekilde; C Hasling; P C Tågehøj Jensen; F Tågehøj Jensen
Journal:  Eur J Clin Invest       Date:  1987-12       Impact factor: 4.686

View more
  13 in total

1.  Effects of a short course of oral phosphate treatment on serum parathyroid hormone(1-84) and biochemical markers of bone turnover: a dose-response study.

Authors:  K Brixen; H K Nielsen; P Charles; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

2.  Fetal antigen 2 (FA2) in human fetal osteoblasts, cultured osteoblasts and osteogenic osteosarcoma cells.

Authors:  D Tornehave; B Teisner; H B Rasmussen; J Chemnitz; M Kassem
Journal:  Anat Embryol (Berl)       Date:  1992-08

3.  Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Authors:  R W Naeraa; K Brixen; R M Hansen; C Hasling; L Mosekilde; J H Andresen; P Charles; J Nielsen
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

4.  Alcohol decreases serum osteocalcin in a dose-dependent way in normal subjects.

Authors:  H K Nielsen; L Lundby; K Rasmussen; P Charles; C Hansen
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

5.  Correlations of serum alkaline phosphatases and bone mineralization rate.

Authors:  J H Himes
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

6.  Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS).

Authors:  P Vestergaard; P Hermann; J-E B Jensen; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2011-06-28       Impact factor: 4.507

7.  Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH.

Authors:  H K Nielsen; J O Jørgensen; K Brixen; J S Christiansen
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

8.  Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits.

Authors:  H K Nielsen; K Brixen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

9.  Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.

Authors:  P Charles; C Hasling; L Risteli; J Risteli; L Mosekilde; E F Eriksen
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

10.  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.

Authors:  Morten M Villadsen; Mathias H Bünger; Mette Carstens; Liselotte Stenkjaer; Bente L Langdahl
Journal:  Osteoporos Int       Date:  2004-08-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.